CLINICAL_TRIALS
trial_result
· 2019-08-06
Clinical Trial Update: An Efficacy and Safety Study of Lanabecestat (LY3314814) in Early Alzheimer's Disease [Phase 2, Phase 3]
Summary
A clinical trial update for lanabecestat in early Alzheimer's disease shows the study conduct with termination and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Alzheimer´s Disease | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2019-08-06